| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 925 |
| 1 | ETANERCEPT | 829 |
| 2 | UPADACITINIB | 714 |
| 3 | METHOTREXATE SODIUM | 460 |
| 4 | METHOTREXATE | 449 |
| 5 | DUPILUMAB | 352 |
| 6 | PREDNISONE | 331 |
| 7 | GABAPENTIN | 278 |
| 8 | ASPIRIN | 277 |
| 9 | ASPIRIN 81 MG | 262 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELOSULFASE ALFA | 73 | 0.0132 |
| 1 | ANTIFUNGAL LIQUID SPRAY | 2 | 0.0106 |
| 2 | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | 34 | 0.0095 |
| 3 | UPADACITINIB | 714 | 0.0084 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 22 | 0.0079 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 68 | 0.0074 |
| 6 | ATROPINE INJECTION, 2 MG | 9 | 0.0061 |
| 7 | CEFACLOR | 7 | 0.0045 |
| 8 | PEXIDARTINIB HYDROCHLORIDE | 3 | 0.0042 |
| 9 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 2 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1405 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 880 |
| 2 | Janus Kinase Inhibitor [EPC] | 729 |
| 3 | Interleukin-23 Antagonist [EPC] | 705 |
| 4 | Corticosteroid [EPC] | 533 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 432 |
| 6 | Vitamin C [EPC] | 360 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 352 |
| 8 | Benzodiazepine [EPC] | 343 |
| 9 | Provitamin D2 Compound [EPC] | 312 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 48 | 0.0698 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 41 | 0.0198 |
| 2 | Provitamin D2 Compound [EPC] | 312 | 0.0105 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 99 | 0.0074 |
| 4 | Interleukin-23 Antagonist [EPC] | 705 | 0.0067 |
| 5 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 6 | PCSK9 Inhibitor [EPC] | 118 | 0.0046 |
| 7 | Janus Kinase Inhibitor [EPC] | 729 | 0.0045 |
| 8 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 29 | 0.0042 |